Resources from the same session
LBA37 - A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)
Presenter: Martin Schuler
Session: Proffered Paper session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA37
Presenter: Evan Lipson
Session: Proffered Paper session: Investigational immunotherapy
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Investigational immunotherapy
Resources:
Webcast
LBA38 - BNT211-01: A phase I trial to evaluate safety and efficacy of CLDN6 CAR T cells and CLDN6-encoding mRNA vaccine-mediated in vivo expansion in patients with CLDN6-positive advanced solid tumours
Presenter: Andreas Mackensen
Session: Proffered Paper session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
728O - Results from phase I dose escalation of IMC-F106C, the first PRAME × CD3 ImmTAC bispecific protein in solid tumors
Presenter: Omid Hamid
Session: Proffered Paper session: Investigational immunotherapy
Resources:
Abstract
Slides
Webcast
Invited Discussant LBA38 TBC and 728O
Presenter: David Braun
Session: Proffered Paper session: Investigational immunotherapy
Resources:
Slides
Webcast